A new review uncovers the crucial role of progranulin in cancer development and progression, offering potential therapeutic targets.
A recent review published in Cancers highlights the significant role of progranulin in cancer development. The growth factor has been found to promote tumor growth by enhancing cancer cell proliferation, migration, and resistance to chemotherapy. It also influences the tumor microenvironment and immune surveillance. Despite these findings, the molecular mechanisms behind progranulin’s oncogenic role are not yet fully understood. Researchers from the Sbarro Health Research Organization and Temple University suggest that further exploration of progranulin could lead to novel therapeutic strategies, including its potential as a diagnostic and prognostic marker for cancer.












